InvestorsHub Logo
Followers 330
Posts 14071
Boards Moderated 2
Alias Born 08/10/2005

Re: kei post# 4193

Wednesday, 02/11/2015 3:20:36 PM

Wednesday, February 11, 2015 3:20:36 PM

Post# of 23979
CRMD is my pick for the year. They have a mixture of Heparin, sodium citrate and an antibacterial product that does not produce bacterial superbugs fro Central line in Hemodialysis patients. It is already approved in Europe.

Risks...they need money and warrants could provide them with the money or they might do an offering. I'm not worried about that because it would be positive for the company.

Also, they have a court case against another company that stole their recipe...and the ruling could come out any day now. All that does bother me as they are the only one that have the rights to market this product in the US.

Currently, they are in phase 3 for this product...talks of partnership and buyout talk have been mentioned.

22 mill O/S...only a 66 mill market cap.

In at 3.07 and will add on any dips

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.